Airway microbiota correlated with pulmonary exacerbation in primary ciliary dyskinesia patients

Area of Science:

• Microbiology
• Pulmonology
• Genetics

Background:

• Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting cilia function.
• Delayed diagnosis of PCD leads to increased antibiotic use, financial burden, and poorer patient outcomes.
• Understanding the respiratory tract microbiota in PCD is crucial for targeted therapies.

Purpose of the Study:

• To characterize the bacterial microbiota in the respiratory tract of pediatric patients with PCD.
• To investigate the differences in microbiota composition between stable and exacerbated disease states.
• To identify specific microbial signatures associated with pulmonary exacerbations in PCD.

Main Methods:

• A large, single-center study involving sequencing of respiratory tract samples from pediatric PCD patients.
• Comparison of microbiota diversity and richness in sputum versus bronchoalveolar lavage fluid (BALF).
• Analysis of microbial community structure during pulmonary stabilization and exacerbation phases.

Main Results:

• The study identified key bacterial microbes in the respiratory tract of pediatric PCD patients.
• Microbiota diversity in pediatric sputum was found to be richer than in pediatric BALF.
• Lower microbiota diversity and richness were observed during pulmonary exacerbations compared to stable periods.
• A significantly higher abundance of *Pseudomonas* was noted during lung exacerbations, suggesting a potential role in disease progression.

Conclusions:

• The respiratory tract microbiota in pediatric PCD exhibits a heterogeneous community structure.
• Pulmonary exacerbations in PCD are associated with reduced microbial diversity and richness.
• *Pseudomonas* may serve as a potential biomarker and therapeutic target for lung exacerbations in pediatric PCD.